- Home
- ZTS vs AMT Comparison
ZTS vs AMT Comparison
Compare ZTS & AMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTS
- AMT
- Stock Information
- Founded
- ZTS 1952
- AMT 1995
- Country
- ZTS United States
- AMT United States
- Employees
- ZTS N/A
- AMT N/A
- Industry
- ZTS Biotechnology: Pharmaceutical Preparations
- AMT Real Estate Investment Trusts
- Sector
- ZTS Health Care
- AMT Real Estate
- Exchange
- ZTS Nasdaq
- AMT Nasdaq
- Market Cap
- ZTS 80.4B
- AMT 82.6B
- IPO Year
- ZTS 2013
- AMT 1998
- Fundamental
- Price
- ZTS $167.47
- AMT $189.93
- Analyst Decision
- ZTS Strong Buy
- AMT Buy
- Analyst Count
- ZTS 8
- AMT 13
- Target Price
- ZTS $215.38
- AMT $230.92
- AVG Volume (30 Days)
- ZTS 2.7M
- AMT 2.5M
- Earning Date
- ZTS 02-13-2025
- AMT 02-25-2025
- Dividend Yield
- ZTS 1.03%
- AMT 3.40%
- EPS Growth
- ZTS 8.38
- AMT 54.72
- EPS
- ZTS 5.32
- AMT 2.37
- Revenue
- ZTS $9,152,000,000.00
- AMT $11,167,700,000.00
- Revenue This Year
- ZTS $9.48
- AMT N/A
- Revenue Next Year
- ZTS $4.87
- AMT N/A
- P/E Ratio
- ZTS $31.51
- AMT $80.04
- Revenue Growth
- ZTS 9.33
- AMT 8.84
- 52 Week Low
- ZTS $144.80
- AMT $170.46
- 52 Week High
- ZTS $200.53
- AMT $243.56
- Technical
- Relative Strength Index (RSI)
- ZTS 49.25
- AMT 54.14
- Support Level
- ZTS $161.58
- AMT $172.51
- Resistance Level
- ZTS $169.78
- AMT $184.69
- Average True Range (ATR)
- ZTS 3.58
- AMT 4.20
- MACD
- ZTS 0.87
- AMT 2.13
- Stochastic Oscillator
- ZTS 74.86
- AMT 81.94
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About AMT American Tower Corporation (REIT)
American Tower owns and operates more than 220,000 cell towers throughout the us, Asia, Latin America, Europe, and Africa. It also owns and/or operates 28 data centers in 10 us markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the us, which accounted for almost half of the company's total revenue in 2023. Outside the us, American Tower operates over 75,000 towers in India, almost 50,000 towers in Latin America (dominated by Brazil), 30,000 towers in Europe, and nearly 25,000 towers in Africa. American Tower operates as an REIT.